Minimally invasive video-assisted mitral valve surgery

A 12-year, 2-center experience in 1178 patients

Paul Modi, Evelio Rodriguez, W. Clark Hargrove, Ansar Hassan, Wilson Y. Szeto, W. Randolph Chitwood

    Research output: Contribution to journalArticle

    91 Citations (Scopus)

    Abstract

    Objective: To review a 2-institution experience with minimally invasive mitral valve surgery over a 12-year period. Methods: We prospectively collected data on all patients having minimally invasive mitral valve surgery through a right minithoracotomy between May 1996 and May 2008. Results: A total of 1178 patients included 941 (79.9%) patients having mitral valve repair and 237 (20.1%) having mitral valve replacement. The mean age was 61.1 ± 13.9 years, mean ejection fraction was 52.8% ± 12.1%, and 221 patients (18.8%) were having reoperations. Operative mortalities for mitral valve repair and mitral valve replacement were 2.1% and 4.6%, and for isolated primary MVP and MVR were 0.2% and 3.6%, respectively. Repair techniques included annuloplasty (98.2%), leaflet resection (40.7%), sliding plasty (21.0%), chordal transfer (9.0%), and neochordae placement (7.4%), with no or trivial residual MR in over 97% of patients. In patients having mitral valve replacement, a bioprosthesis was placed in 101 patients (42.6%) and a mechanical valve in 136 (57.4%). Concomitant procedures included atrial fibrillation ablation (22.5%), tricuspid valve surgery (5.4%), and atrial septal defect closure (9.4%). Nineteen patients (1.6%) experienced intraoperative conversion to sternotomy. Twenty-two patients (1.9%) had a reoperation at a mean of 732 ± 1014 days. Independent predictors of in-hospital mortality included New York Heart Association class III/IV (odds ratio 3.62), diabetes (odds ratio 2.81), bypass time > 180 minutes (odds ratio 2.63), preoperative atrial fibrillation (odds ratio 2.53), and age > 70 years (odds ratio 2.29). Prior cardiac surgery was not a significant predictor of mortality. Conclusions: Video-assisted mitral valve surgery is safe with high rates of repair, low morbidity, and excellent outcomes. Reoperation after previous median sternotomy is not an independent predictor of mortality with this approach. Operative risk is increased if surgery is delayed until the onset of atrial fibrillation.

    Original languageEnglish (US)
    Pages (from-to)1481-1487
    Number of pages7
    JournalJournal of Thoracic and Cardiovascular Surgery
    Volume137
    Issue number6
    DOIs
    StatePublished - Jun 1 2009

    Fingerprint

    compound A 12
    Mitral Valve
    Odds Ratio
    Reoperation
    Atrial Fibrillation
    Sternotomy
    Mortality
    Bioprosthesis
    Tricuspid Valve
    Atrial Heart Septal Defects
    Hospital Mortality
    Thoracic Surgery
    Morbidity

    All Science Journal Classification (ASJC) codes

    • Cardiology and Cardiovascular Medicine
    • Surgery
    • Pulmonary and Respiratory Medicine

    Cite this

    Minimally invasive video-assisted mitral valve surgery : A 12-year, 2-center experience in 1178 patients. / Modi, Paul; Rodriguez, Evelio; Hargrove, W. Clark; Hassan, Ansar; Szeto, Wilson Y.; Chitwood, W. Randolph.

    In: Journal of Thoracic and Cardiovascular Surgery, Vol. 137, No. 6, 01.06.2009, p. 1481-1487.

    Research output: Contribution to journalArticle

    Modi, Paul ; Rodriguez, Evelio ; Hargrove, W. Clark ; Hassan, Ansar ; Szeto, Wilson Y. ; Chitwood, W. Randolph. / Minimally invasive video-assisted mitral valve surgery : A 12-year, 2-center experience in 1178 patients. In: Journal of Thoracic and Cardiovascular Surgery. 2009 ; Vol. 137, No. 6. pp. 1481-1487.
    @article{f4caa73d5b084968999c70eb02547d5b,
    title = "Minimally invasive video-assisted mitral valve surgery: A 12-year, 2-center experience in 1178 patients",
    abstract = "Objective: To review a 2-institution experience with minimally invasive mitral valve surgery over a 12-year period. Methods: We prospectively collected data on all patients having minimally invasive mitral valve surgery through a right minithoracotomy between May 1996 and May 2008. Results: A total of 1178 patients included 941 (79.9{\%}) patients having mitral valve repair and 237 (20.1{\%}) having mitral valve replacement. The mean age was 61.1 ± 13.9 years, mean ejection fraction was 52.8{\%} ± 12.1{\%}, and 221 patients (18.8{\%}) were having reoperations. Operative mortalities for mitral valve repair and mitral valve replacement were 2.1{\%} and 4.6{\%}, and for isolated primary MVP and MVR were 0.2{\%} and 3.6{\%}, respectively. Repair techniques included annuloplasty (98.2{\%}), leaflet resection (40.7{\%}), sliding plasty (21.0{\%}), chordal transfer (9.0{\%}), and neochordae placement (7.4{\%}), with no or trivial residual MR in over 97{\%} of patients. In patients having mitral valve replacement, a bioprosthesis was placed in 101 patients (42.6{\%}) and a mechanical valve in 136 (57.4{\%}). Concomitant procedures included atrial fibrillation ablation (22.5{\%}), tricuspid valve surgery (5.4{\%}), and atrial septal defect closure (9.4{\%}). Nineteen patients (1.6{\%}) experienced intraoperative conversion to sternotomy. Twenty-two patients (1.9{\%}) had a reoperation at a mean of 732 ± 1014 days. Independent predictors of in-hospital mortality included New York Heart Association class III/IV (odds ratio 3.62), diabetes (odds ratio 2.81), bypass time > 180 minutes (odds ratio 2.63), preoperative atrial fibrillation (odds ratio 2.53), and age > 70 years (odds ratio 2.29). Prior cardiac surgery was not a significant predictor of mortality. Conclusions: Video-assisted mitral valve surgery is safe with high rates of repair, low morbidity, and excellent outcomes. Reoperation after previous median sternotomy is not an independent predictor of mortality with this approach. Operative risk is increased if surgery is delayed until the onset of atrial fibrillation.",
    author = "Paul Modi and Evelio Rodriguez and Hargrove, {W. Clark} and Ansar Hassan and Szeto, {Wilson Y.} and Chitwood, {W. Randolph}",
    year = "2009",
    month = "6",
    day = "1",
    doi = "10.1016/j.jtcvs.2008.11.041",
    language = "English (US)",
    volume = "137",
    pages = "1481--1487",
    journal = "Journal of Thoracic and Cardiovascular Surgery",
    issn = "0022-5223",
    publisher = "Mosby Inc.",
    number = "6",

    }

    TY - JOUR

    T1 - Minimally invasive video-assisted mitral valve surgery

    T2 - A 12-year, 2-center experience in 1178 patients

    AU - Modi, Paul

    AU - Rodriguez, Evelio

    AU - Hargrove, W. Clark

    AU - Hassan, Ansar

    AU - Szeto, Wilson Y.

    AU - Chitwood, W. Randolph

    PY - 2009/6/1

    Y1 - 2009/6/1

    N2 - Objective: To review a 2-institution experience with minimally invasive mitral valve surgery over a 12-year period. Methods: We prospectively collected data on all patients having minimally invasive mitral valve surgery through a right minithoracotomy between May 1996 and May 2008. Results: A total of 1178 patients included 941 (79.9%) patients having mitral valve repair and 237 (20.1%) having mitral valve replacement. The mean age was 61.1 ± 13.9 years, mean ejection fraction was 52.8% ± 12.1%, and 221 patients (18.8%) were having reoperations. Operative mortalities for mitral valve repair and mitral valve replacement were 2.1% and 4.6%, and for isolated primary MVP and MVR were 0.2% and 3.6%, respectively. Repair techniques included annuloplasty (98.2%), leaflet resection (40.7%), sliding plasty (21.0%), chordal transfer (9.0%), and neochordae placement (7.4%), with no or trivial residual MR in over 97% of patients. In patients having mitral valve replacement, a bioprosthesis was placed in 101 patients (42.6%) and a mechanical valve in 136 (57.4%). Concomitant procedures included atrial fibrillation ablation (22.5%), tricuspid valve surgery (5.4%), and atrial septal defect closure (9.4%). Nineteen patients (1.6%) experienced intraoperative conversion to sternotomy. Twenty-two patients (1.9%) had a reoperation at a mean of 732 ± 1014 days. Independent predictors of in-hospital mortality included New York Heart Association class III/IV (odds ratio 3.62), diabetes (odds ratio 2.81), bypass time > 180 minutes (odds ratio 2.63), preoperative atrial fibrillation (odds ratio 2.53), and age > 70 years (odds ratio 2.29). Prior cardiac surgery was not a significant predictor of mortality. Conclusions: Video-assisted mitral valve surgery is safe with high rates of repair, low morbidity, and excellent outcomes. Reoperation after previous median sternotomy is not an independent predictor of mortality with this approach. Operative risk is increased if surgery is delayed until the onset of atrial fibrillation.

    AB - Objective: To review a 2-institution experience with minimally invasive mitral valve surgery over a 12-year period. Methods: We prospectively collected data on all patients having minimally invasive mitral valve surgery through a right minithoracotomy between May 1996 and May 2008. Results: A total of 1178 patients included 941 (79.9%) patients having mitral valve repair and 237 (20.1%) having mitral valve replacement. The mean age was 61.1 ± 13.9 years, mean ejection fraction was 52.8% ± 12.1%, and 221 patients (18.8%) were having reoperations. Operative mortalities for mitral valve repair and mitral valve replacement were 2.1% and 4.6%, and for isolated primary MVP and MVR were 0.2% and 3.6%, respectively. Repair techniques included annuloplasty (98.2%), leaflet resection (40.7%), sliding plasty (21.0%), chordal transfer (9.0%), and neochordae placement (7.4%), with no or trivial residual MR in over 97% of patients. In patients having mitral valve replacement, a bioprosthesis was placed in 101 patients (42.6%) and a mechanical valve in 136 (57.4%). Concomitant procedures included atrial fibrillation ablation (22.5%), tricuspid valve surgery (5.4%), and atrial septal defect closure (9.4%). Nineteen patients (1.6%) experienced intraoperative conversion to sternotomy. Twenty-two patients (1.9%) had a reoperation at a mean of 732 ± 1014 days. Independent predictors of in-hospital mortality included New York Heart Association class III/IV (odds ratio 3.62), diabetes (odds ratio 2.81), bypass time > 180 minutes (odds ratio 2.63), preoperative atrial fibrillation (odds ratio 2.53), and age > 70 years (odds ratio 2.29). Prior cardiac surgery was not a significant predictor of mortality. Conclusions: Video-assisted mitral valve surgery is safe with high rates of repair, low morbidity, and excellent outcomes. Reoperation after previous median sternotomy is not an independent predictor of mortality with this approach. Operative risk is increased if surgery is delayed until the onset of atrial fibrillation.

    UR - http://www.scopus.com/inward/record.url?scp=67349122901&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=67349122901&partnerID=8YFLogxK

    U2 - 10.1016/j.jtcvs.2008.11.041

    DO - 10.1016/j.jtcvs.2008.11.041

    M3 - Article

    VL - 137

    SP - 1481

    EP - 1487

    JO - Journal of Thoracic and Cardiovascular Surgery

    JF - Journal of Thoracic and Cardiovascular Surgery

    SN - 0022-5223

    IS - 6

    ER -